Figure 4e shows that 8 of 18 tumours had mutations or PTEN deficiency, meaning that only 3 of the PIK3CA/ERBB-mutant tumours (from Fig. 4c) are included in the composite analysis in Fig. 4e. This evidence concerns the gene PTEN and neoplasm.